940 related articles for article (PubMed ID: 33724184)
1. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
Elife; 2021 Mar; 10():. PubMed ID: 33724184
[TBL] [Abstract][Full Text] [Related]
2. Prenatal methadone exposure and child developmental outcomes in 2-year-old children.
Levine TA; Davie-Gray A; Kim HM; Lee SJ; Woodward LJ
Dev Med Child Neurol; 2021 Sep; 63(9):1114-1122. PubMed ID: 33462809
[TBL] [Abstract][Full Text] [Related]
3. Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months.
Wouldes TA; Woodward LJ
PLoS One; 2020; 15(10):e0240905. PubMed ID: 33064777
[TBL] [Abstract][Full Text] [Related]
4. Opioids affect the fetal brain: reframing the detoxification debate.
Caritis SN; Panigrahy A
Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
[TBL] [Abstract][Full Text] [Related]
5. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
6. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
7. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
[TBL] [Abstract][Full Text] [Related]
8. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
10. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.
Jansson LM; Di Pietro JA; Elko A; Williams EL; Milio L; Velez M
Drug Alcohol Depend; 2012 May; 122(3):213-9. PubMed ID: 22041255
[TBL] [Abstract][Full Text] [Related]
11. Alterations of brain microstructures in a mouse model of prenatal opioid exposure detected by diffusion MRI.
Grecco GG; Shahid SS; Atwood BK; Wu YC
Sci Rep; 2022 Oct; 12(1):17085. PubMed ID: 36224335
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
Kaltenbach K; O'Grady KE; Heil SH; Salisbury AL; Coyle MG; Fischer G; Martin PR; Stine S; Jones HE
Drug Alcohol Depend; 2018 Apr; 185():40-49. PubMed ID: 29413437
[TBL] [Abstract][Full Text] [Related]
13. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019.
Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
16. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
17. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
Jones HE; Finnegan LP; Kaltenbach K
Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Management of Opioid Use Disorder in Pregnant Women.
Wilder CM; Winhusen T
CNS Drugs; 2015 Aug; 29(8):625-36. PubMed ID: 26315948
[TBL] [Abstract][Full Text] [Related]
19. Prenatal methadone exposure impairs adolescent cognition and GABAergic neurodevelopment in a novel rat model of maternal methadone treatment.
Lum JS; Bird KM; Wilkie J; Millard SJ; Pallimulla S; Newell KA; Wright IM
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110281. PubMed ID: 33571606
[TBL] [Abstract][Full Text] [Related]
20. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
